EP Patent

EP0248531A2 — Encapsulated nucleic acids

Assigned to Southern Research Institute · Expires 1987-12-09 · 38y expired

What this patent protects

RNA and/or DNA, e.g. poly(I:C) or anti-sense RNA, is encapsulated as microcapsules in a biodegradable, biocompatible polymeric material, for the controlled release of the nucleic acid on administration and the induction of interferon production.

USPTO Abstract

RNA and/or DNA, e.g. poly(I:C) or anti-sense RNA, is encapsulated as microcapsules in a biodegradable, biocompatible polymeric material, for the controlled release of the nucleic acid on administration and the induction of interferon production.

Drugs covered by this patent

Patent Metadata

Patent number
EP0248531A2
Jurisdiction
EP
Classification
—
Expires
1987-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Southern Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.